A topical dosage form of liposomal clofazimine: research and clinical implications.
A novel topical clofazimine (CLO) gel formulation containing liposomally encapsulated CLO, was prepared and investigated in vitro followed by a clinical evaluation. CLO liposomes were prepared by the lipid film hydration technique. Comparative in vitro diffusion studies were conducted with plain and liposomal CLO in HPMC K4M gel base (2% and 5%) using human cadaver skin (HCS). A double blind clinical study was conducted on eight leprosy patients. The results of these studies show that the new liposomal topical gel formulation not only prolongs the drug release but also promotes drug retention by the skin. Studies further support formation of a reservoir of drug on the skin modifying therapeutic efficacy of the formulation. The new liposomal gel formulation of CLO considerably reduces the healing time of external lesions due to a significantly prolonged skin residence time compared to plain CLO gel and hence is expected to reduce the time needed for leprosy treatment.
Pharmacy Department, Faculty of Technology and Engineering, M.S. University of Baroda, India.
V B
VB
Patel
A N
AN
Misra
Y S
YS
Marfatia
D000287:Administration, Topical; D002511:Cephalosporins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002991:Clofazimine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004058:Diffusion; D004311:Double-Blind Method; D005260:Female; D005782:Gels; D006801:Humans; D066298:In Vitro Techniques; D008081:Liposomes; D008297:Male
D002511:Cephalosporins; D005782:Gels; D008081:Liposomes; D002991:Clofazimine